MiR-335-5p inhibits β-Amyloid (Aβ) accumulation to attenuate cognitive deficits through targeting c-jun-N-terminal kinase 3 in alzheimer's disease.

CONCLUSION: The results revealed that the increased JNK3 expression, negatively regulated by miR-335-5p, maybe a potential mechanism that contributes to Aβ accumulation and AD progression, indicating a novel approach for AD treatment. PMID: 32003672 [PubMed - as supplied by publisher]
Source: Current Neurovascular Research - Category: Neurology Authors: Tags: Curr Neurovasc Res Source Type: research